Open Access

Vijaykumar Nimbarte

• The work of this thesis focuses on the targeting of G-quadruplexes (G4s), wherein several specific and potential ligands were designed, synthesized and characterized for its structural and biological activity. G4s are nucleic acid secondary structures that may form in single-stranded guanine (G)-rich sequences under physiological conditions. Four Guanines (Gs) bind via Hoogsteen-type hydrogen bonds base pairing to yield G-quartets, which in turn stack on top of each other to form the G4. G4s are highly polymorphic, both in terms of strand stoichiometry (forming both inter and intramolecular structures) and strand orientation/topology. The presence of K+ cations specifically supports G4 formation and stability. In the human genome G4 DNA motifs have been found in telomeres, G-rich micro and mini-satellites, up-stream to oncogene promoters and within the ribosomal DNA (rDNA). Human G4 DNA motifs are over-expressed in recombinogenic regions, which are associated with genomic damage in cancer cells. In the present work, we focus on lead identification with specificity towards the c-MYC promoter G4s. Drug discovery is a highly time consuming and costly process. Lead identification and development are key steps in the drug discovery program. Studies have suggested that a large number of commercially available drugs exhibit deep structural similarity to the lead compounds from which they were developed. Quality lead identification in terms of compounds with high potency and selectivity, favorable physicochemical parameters and in vitro Absorption Distribution Metabolism and Excretion (ADME) parameters are the foremost requirements for the success of the drug discovery process. We herein describe the fragment-based drug design approach for the development of pyrrolidine-substituted 5-nitroindole derivatives as a new class of G4 ligands that exhibit high affinity and selectivity for the c-MYC promoter G-quadruplex. This chapter focuses on the methodology explored whilst finding a suitable hit and its optimization with fragment expansion strategies which undergo efficient G4 binding. To target G4 DNA, screenings of numerous heterocycles have been reported including indoles, 7-azaindoles, 1H-indazol-3-yl, benzothiazole, imidazo[1,5-a]pyridine, 2,6- diaminopyrimidin-4-ol, 1H-pyrazolo[4,3 d]pyrimidin-7-amine, morpholino, bis-indoles, 2-hydroxynaphthalene-1,4-dione, 1,4-dihydroxyanthracene-9,10-dione, benzofuran and piperonal derived from several alkaloids. In this part of the thesis, we set out to identify new binders targeting the c-MYC G-quadruplex starting from the indole fragment. Several synthetic strategies are reported to optimize and generate best hits starting from 5-nitro indole derivatives by introducing the secondary cationic linked pyrrolidine side chain. Interestingly, all improved versions of G4-indole fragments 5, 7 and 12 contain this 5-nitro functionality, which may aid in the electrostatic binding and contributes to hydrogen binding interactions of the ligands to G4 DNA. In-silico drug design, biological and biophysical analyses illustrated that the substituted 5-nitro indoles scaffolds show preferential affinity towards the c-MYC promoter G-quadruplex compared to other G-quadruplexes and double stranded DNA. In vitro cellular studies confirm that the substituted indole scaffolds downregulate c-MYC expression in cancer cells and have the potential to induce cell cycle arrest in the G0/G1 phase. NMR analysis suggests that 5, 7, and 12 interacts in a fast exchange regime with the terminal G-quartets (5’ and 3’end) in a 2:1 stoichiometry. To further optimize the fragment generated in chapter II, a novel series of triazole linked indole derivatives as a potential G quadruplex stabilizers have been described in chapter III. The potential ligands can be obtained through an efficient, convergent, synthetic route in moderate to good yields. The synthesized triazole linked indole derivatives are selective towards c- MYC G4-DNA vs. duplex-DNA. The planarity of the aromatic core and its ability to occupy more surface area by stacking over the G4 greatly affect the ability of the compounds to stabilize the G4. Further biophysical and biological studies revealed that the triazole linked nitro indoles are more promising than the amino indole derivatives. Additionally, the importance of the nitro functional group has been justified by molecular docking studies, where hydrogen-bonding interactions were observed in between the nitro group and the G4 base pairs of the G-quadruplex. In biological findings, most of the synthesized triazole linked nitro indoles has found to be effective against human carcinoma (cervical) HeLa cell lines. Furthermore, western blot and cell cycle analysis confirms that the novel triazole linked 5-nitro indole derivatives (9b) could down-regulate c-MYC oncogene expression in cancer cells via stabilizing its promoter quadruplex structure, arresting cell cycle in G0/G1 phase. NMR analysis suggests that 9b interacts in slow exchange regime with the terminal G-quartets (5’ and 3’-end). In chapter IV of the thesis, we have developed the synthetic strategies to generate more potent G4 ligands via Knoevenagel condensation. To investigate novel and selective G4 ligands for cancer chemotherapy, we designed and synthesized a series of azaindolin-2-one derivatives (11, 14, 15, 16 and 22) by attaching cationic pyrrolidine side chains and introducing a fluorine atom into the aromatic chromophore (Fig. 3). Fluorine atoms, with high electronegativity and small size, often exhibit unique properties in functional molecules. The electron-withdrawing effect of fluorine could reduce the electron density of the aromatic chromophore, which might favor a stronger interaction with the electron-rich π-system of the G-quartet. In addition, the introduction of fluorine atoms into small molecules might improve lipophilicity and thus the bioavailability. Fluorescent indicator displacement assay (FID) assays suggests that the synthesized azaindolin-2-one derivatives are selective towards c-MYC G4-DNA vs. duplex-DNA and showed potent anticancer activity against human carcinoma (cervical) HeLa cell lines. They down-regulate c-MYC expression in cancer cells via stabilizing its promoter quadruplex structure, arresting cell cycle in G0/G1 phase. Furthermore, NMR spectroscopy suggests that azaindolin-2-one conjugate interacts with terminal G-quartets as well as with the nearby G-rich tract (G13-G14-G15 and G8-G9-G10) of c-MYC quadruplex in intermediate exchange regime.